| Literature DB >> 23244416 |
Rakesh Bodhicharla1, Archana Nagarajan, Jody Winter, Ademola Adenle, Aamir Nazir, Declan Brady, Kelly Vere, Jo Richens, Paul O'Shea, David R Bell, David de Pomerai.
Abstract
The neural protein α-synuclein aggregates both in vivo and in vitro to form insoluble fibrils that are involved in Parkinson's disease pathogenesis. We have generated α-synuclein/fluorescent-protein fusion constructs overexpressed in muscle cells of the nematode, Caenorhabdtis elegans. Green Fluorescent Protein (GFP) variants, Cerulean (C) or Venus (V), were fused to the C-terminus of human α-synuclein (S); the resultant fusion genes were designated SV and SC, plus a CV fusion as well as S, C and V singly. The aggregation behavior of the purified fusion proteins (expressed in E. coli) will be described elsewhere. These constructs were fused to a C. elegans unc-54 myosin promoter, and integrated transgenic lines generated by microinjection, λ-irradiation, and outcrossing of fluorescent progeny. All transgenic lines expressing α- synuclein showed significant reductions (p <0.05) in lifespan, motility and pharyngeal pumping, as compared to wildtype worms or lines expressing CFP and/or YFP only. We showed that CFP and YFP labels colocalised in granular inclusions throughout the body wall in transgenic lines expressing both SC and SV fusions (SC+SV), whereas SV+C worms displayed YFP-labelled inclusions on a diffuse CFP background. These findings implied that the α-synuclein moieties of these fusion proteins still aggregated together in vivo, whereas CFP or YFP moieties alone did not. This in turn suggested that Foerster Resonanace Energy Transfer (FRET) between CFP and YFP labels in α-synuclein aggregates could allow the extent of aggregation to be quantified. Accordingly, we also showed that net FRET signals increased 2- fold between L4 and adult SC+SV worms.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23244416 PMCID: PMC3744922 DOI: 10.2174/1871527311211080005
Source DB: PubMed Journal: CNS Neurol Disord Drug Targets ISSN: 1871-5273 Impact factor: 4.388
Transgenes and Gene Constructs
| No. | Transgene and Integration Status | Gene Construct with Restriction Sites |
|---|---|---|
| 1 | Cerulean (C) Non-integrated | NcoI-Cerulean-SacI |
| 2 | Venus (V) Integrated | NcoI-Venus-SacI |
| 3 | Cerulean + Venus (C+V) Integrated | NcoI-Cerulean-SacI + NcoI-Venus-SacI |
| 4 | Cerulean-Venus Integrated | NcoI-Cerulean-Csp45I/Csp45I-Venus-SacI |
| 5 | Synuclein + Venus Integrated | NcoI-Synuclein-SacI/NcoI-Venus-SacI |
| 6 | Synuclein-Venus (SV) Non-integrated | NcoI-Synuclein-Csp45I + Csp45I-Venus-SacI |
| 7 | Synuclein-Venus + Synuclein-Cerulean Integrated | NcoI-Synuclein-Csp45I/Csp45I-Venus-SacI + NcoI-Synuclein-Csp45I/Csp45I-Cerulean-SacI |
List of all the transgenes expressed in C. elegans using the unc-54 promoter. Restriction enzymes were added to cut these gene constructs and various combinations used for construction of gene-fusions as indicated in the table. The genes were cloned into pGEMT-easy plasmid and sub-cloned into pET30a and subsequently into pPD30.38 (Fire lab vector, Addgene; http://www.addgene.org/firelab/ ) incorporating the unc-54 promoter site. A slash (/) designates fusion of the sequences indicated, whereas a plus sign (+) indicates a mixture of both sequences. The integration status of each strain is indicated in the second column.
Although our own unc-54::SV strain was non-integrated, a very similar construct is fully integrated in strain NL5901.
| Trait | MS |
|
|
| N2 Control (Mean ± SD) |
|---|---|---|---|---|---|
| Egg to adult development time | 9.881 | 1.031 | 0.448 | 74 ± 3 hours | |
| Brood size | 320.1 | 7 | 0.326 | 0.938 | 284.2 ± 45.7 eggs |
| Pharyngeal pumping rate | 1305 | 6 | 8.061 | < 0.0001 | 195.8 ± 5.2 pumps/min |
| Locomotion rate | 85.28 | 6 | 21.76 | < 0.0001 | 14.2 ± 1.5 bends/min |
Summary of One-Way ANOVA tests performed on egg to adult development time, brood size, pharyngeal pumping rate and locomotion rate, where strain was treated as a fixed factor. Units of analysis and mean N2 control values (± SD) are shown in the final column
Summary of Advantages and Drawbacks of C. elegans Models for Parkinson’s Disease
| SC+SV | NL 5901 | Pdat-1 : WT and A53T and Paex-3:WT and A53T | |
|---|---|---|---|
| Expression | Body-wall muscle cells ( | Body-wall muscle cells ( | Either pan-neuronally ( |
| Gene expression and RNAi studies? | Yes | Yes | Yes |
| Strong signal (reflecting higher expression levels)? | Yes | Yes | No (better for |
| Relevance to human Parkinson’s disease? | Limited to synuclein aggregation | Limited to synuclein aggregation | Yes (construct expressed in neuronal cells). |
| Quantification of aggregation? | Yes (using FRET) | Indirect (requires image analysis) | Indirect (requires image analysis) |
| High-throughput? | Yes (using FRET) | No (requires image analysis) | No (requires image analysis) |